hypothesis 1,658 words
Contents

Mitochondria-Lysosome Contact Sites Dysfunction in Parkinson's Disease

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (145)

TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.87
Mitochondrial SPM Synthesis Platform Engineering
Score: 0.65
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.90
APOE-Dependent Autophagy Restoration
Score: 0.88
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.77
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Transcriptional Autophagy-Lysosome Coupling
Score: 0.76
Multi-Modal Stress Response Harmonization
Score: 0.76
Senescence-Activated NAD+ Depletion Rescue
Score: 0.76
pg 1/8Next →

Related Analyses (30)

Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40

See Also (6)

ABCA7 (Redirect)
redirect · KG edge: associated_with
ABCD3 Gene
gene · KG edge: activates
ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: expressed_in
ACTB Gene
gene · KG edge: activates
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates

Knowledge Graph (8 edges)

Mitochondrial Dysfunction associated_with Mitochondria-Lysosome Contacts
Mitochondria-Lysosome Contacts mediates Mitochondrial Calcium Transfer
Mitochondria-Lysosome Pathway involved_in Immune Signalling
Mitochondria-Lysosome Contacts associated_with Calcium Transfer
Mucolipidosis Type Iv associated_with Mitochondria-Lysosome Contacts
Lysosomal Dysfunction associated_with Mitochondria-Lysosome Contacts
Mitochondria-Lysosome Contacts regulates Mitochondrial Dynamics
TBC1D15 regulates Mitochondria-Lysosome Interaction

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.